Background: Patients with adult congenital heart disease (ACHD) have an increased risk of arrhythmic and sudden cardiac death. The subcutaneous implantable cardioverter defibrillator (S-ICD) provides a potentially safer alternative to transvenous ICDs in ACHD. Suitability for S-ICD depends on the surface electrocardiogram (ECG), which is often abnormal in ACHD patients. This study investigates the proportion of ACHD patients who meet the screening criteria for S-ICD implantation.
INTRODUCTION
Patients with adult congenital heart disease (ACHD) have an increased risk of sudden cardiac death due to tachyarrhythmias. Those most at risk are patients with repaired tetralogy of Fallot (TOF) 1 and complete transposition of the great arteries (D-TGA) 2 and Fontan circulation. 3 The 2014 HRC/PACES guidelines 4 recommend implantable cardioverter defibrillator (ICD) implantation in ACHD patients with poor systemic ventricular function, following hemodynamically significant ventricular arrhythmias and in selected higher-risk patients with TOF.
Unfortunately, transvenous ICD implantation can be challenging in the ACHD population, as a result of their complex anatomy and associated risks of procedural complications. 5 Particular difficulty exists following the Fontan procedure for single ventricle, which often precludes access from the venous system to the heart. 6 Systemic venous pathway obstruction has also been reported in 36% of D-TGA patients. 7 In addition, lead failure, resulting from growth-related lead distortion, is common, with incidence rates as high as 26%. 8 The most recent development in ICD design is the subcutaneous ICD (S-ICD) system, which comprises a generator placed in the anterolateral position, and a left parasternal coil placement. The absence of transvenous access preserves the vasculature and is thought to minimize procedure-related complications, risk of bleeding, thrombosis, and infection. 5 The S-ICD is an attractive option in ACHD patients who are likely to require multiple generator changes in their lifetime and face potential complications with each intervention, particularly when transvenous access to the ventricles is difficult. Their use in this population is recommended by the European Society of Cardiology. 9 ACHD patients frequently have abnormal electrocardiograms (ECGs), which may interfere with appropriate sensing, and it is unclear what proportion of ACHD patients would be suitable for an S-ICD.
Prior to S-ICD implantation, ECG screening must be performed to ensure that T waves are not oversensed and shocks are delivered appropriately. This involves assessment of an appropriate R to T (R:T) wave ratio. Screening data for ACHD patients are limited and only small sample studies of around 30 patients have so far been carried out, with reported ineligibility rates between 13.3% 10 and 48.4%. 11 Independent predictors of ineligibility include prolonged QRS duration, a R:T max value of less than 3, 12 and T-wave inversion. 13 This study investigates what proportion of patients with ACHD meet the ECG screening criteria for an S-ICD.
METHODS
In this prospective study, patients were recruited from the ACHD patient population in a large quaternary specialist ACHD center 
Study design
The screening ECG was carried out according to the S-ICD manufacturer's protocol, 14 Demographic information and clinical data were recorded for all ACHD participants and ECG data were extracted from their most recent 12-lead ECG. The R:T max was defined as the ratio of the R wave to T wave in the lead with the largest amplitude T wave.
Statistical analysis
For analysis of clinical and electrographic features, categorical data are expressed as percentages and were analyzed using the Fisher's exact test. Continuous data were assessed using the Kolmogorov- Smirnov test and expressed, depending on its normality. For normally distributed data, the mean and standard deviation were calculated and an independent t-test was used. For data that were not normally distributed, the median and interquartile range were calculated and compared using the Mann-Whitney U Test. The statistics software package SPSS 22.0 (IBM, Armonk, NY, USA) was used for data collection and analysis.
RESULTS
A total of 107 ACHD patients were recruited. Of these, five (4.6%) patients were excluded due to a lack of ECG data in all three postures or at additional gain settings. The complete screening ECG was obtained in 102 participants, 14 (13.7%) of whom also had the protocol repeated postexercise. As shown in Table 1 , the mean age was 30.7 (±1.19) years (mean ± standard deviation) and a total of 54 (53.0%) patients were female. In addition to their primary diagnosis, five (4.9%) patients also had dextrocardia and 61 (59.8%) had a bundle branch block, of which 83.6% were right bundle branch block (RBBB).
Eligibility
A total of 77 (75.4%) patients were deemed potentially eligible for an S-ICD with at least one suitable vector. The primary vector was the most common suitable vector found in 48 (62%) participants who had appropriate sensing vectors. The most common number of acceptable vectors in the eligible group was two (n = 36, 47%), whereas only 12 (16%) had all three acceptable vectors and 29 (38%) had only one suitable vector. 
Reasons for ineligibility
Only one Fontan patient was deemed ineligible (P = 0.01). In contrast over a third (n = 14, 36%) of patients with TOF were ineligible (P = 0.001). The measured R:Tmax ratio was significantly smaller in the ineligible group (P = 0.03), with a mean value of 1.8 for the ineligible group and 2.9 for the eligible group, respectively. The QRS duration in the ineligible group was significantly broader (P = 0.01) with a greater Continuous data provided as mean ± standard deviation. P values refer to differences between eligible and ineligible groups. BMI = body mass index; ECG = electrocardiogram; LBBB = left bundle branch block; RBBB = right bundle branch block; R:Tmax = R:T on the maximum T wave; TGA = transposition of the great arteries; TOF = tetralogy of Fallot.
proportion having RBBB rather than left bundle branch block (LBBB) morphology (P < 0.01). Consequently, the number of patients with a narrow QRS was significantly lower in the ineligible group (P = 0.02). 
DISCUSSION
This study shows that nearly a quarter of ACHD patients fail to meet shock rate. 15 Ferro et al. showed similar outcomes in eight patients with S-ICD and ACHD in the secondary prevention setting. 16 The main F I G U R E 4 Change in measured R wave amplitude seen across the postures, in both the eligible and ineligible groups reason for this approach was the inability to implant a standard ICD percutaneously. This group showed a similar inappropriate shock rate (12.5%).
Effect of disease
Olde Nordkamp et al. 12 found an S-ICD ineligibility rate of 7.4% in the general cardiac population based on ECG screening. The significantly higher ineligibility rates in the ACHD population seen in this study may be due to abnormal T-wave morphology, 17 resulting from structural and functional disturbances that characterizes ACHD, including cardiac chamber enlargement, abnormal cardiac position, mechanical strain, and augmented repolarization. 18 Ineligibility was highest in patients with TOF. This is perhaps not unexpected, as patients with TOF may have right ventricular dilatation due to volume overload resulting from pulmonary regurgitation. 19 Moreover, TOF patients also have conduction abnormalities and frequently have prolonged QRS complexes. Indeed QRS duration is one of the major criteria for predicting the risk of SCD and arrhythmia in patients with TOF. 4 Patients with TOF are at particularly high risk of monomorphic ventricular tachycardia, which often responds to antitachycardia pacing. For this reason also, transvenous ICD may be preferable to an S-ICD in patients with TOF.
In contrast, we found that up to 93% of patients with a Fontan circu- that there was no reduction in the R wave or T wave using the right parasternal position to screen compared to the standard technique in a mixed group of congenital patients (TOF, transposition and single ventricle). 21 There was, however, a significant reduction in these vectors in control patients. Alonzo et al. screened 102 patients with TOF and found 34% were ineligible for S-ICD with standard screening but only 25% were ineligible with right-sided screening. 22 The highest rates of ineligibility were found in those patients with the most risk factors for sudden death. In contrast, they found no additional benefit of right-sided screening in patients with a single ventricle. Okamura et al. 23 showed a much lower rate of ineligibility (21%) using standard screening in a cohort of 100 ACHD patients. This was reduced to 12%
by right-sided screening. However, the vast majority of their patients had simple rather than complex congenital heart disease and only 22 had TOF. In summary, right-sided placement of an ICD may allow a higher proportion of ACHD patients to be eligible for an S-ICD, particularly those with TOF, but may pose difficulties in the patients who required additional sternotomies. The benefits in other types of congenital heart disease appear limited.
Effect of posture
This study shows that significant proportion of ACHD patients has acceptable vectors in one or two postures, but were ultimately deemed ineligible due to altered R:T upon change in posture, which resulted in the R or T wave falling outside the screening template. This highlights the sensitivity of the subcutaneous sensing electrode to variations in QRS morphology with cardiac orientation. Together with significant changes in R wave amplitude seen across all three postures, this supports screening in multiple positions as a prerequisite for identifying such changes that could affect the function of the S-ICD.
Exercise
Kooiman et al 24 suggested that exercise would render a large proportion of ineligible patients, as a result of exercise-induced changes in QRS and T-wave morphology. Although only a small proportion of patients underwent exercise testing in this study, it only had a small impact on eligibility in patients with ACHD.
Limitations
This study only included the most common forms of ACHD for whom an ICD may be indicated; others, such as atrioventricular septal defects or Ebstein's anomaly, were excluded. Only standard ECG screening was performed; right parasternal lead positions were not assessed, which may have improved the eligibility. Only a small proportion of patients underwent exercise testing.
CONCLUSIONS
Patients with ACHD are at increased risk of ventricular arrhythmias and sudden death, and the use of transvenous ICDs can be difficult because of the complex venous anatomy and high complication rates.
They would appear to be good candidates for the S-ICD. This study demonstrates that using standard ECG screening, nearly a quarter of patients with the commonest ACHD indications for ICD are not eligible candidates for the S-ICD, due to a risk of inappropriate sensing.
In contrast, the vast majority of patients with a Fontan circulation are suitable for the S-ICD. In these patients, placing a transvenous ICD lead is usually not possible and S-ICD offers a relatively low-risk approach to allow ICD therapy. While improvements to the current screening protocol are expected, they are unlikely to have a significant impact on eligibility without substantial development of the current S-ICD sensing algorithm.
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